ARCHIVES

Velcade Improves Survival In Relapsed Multiple Myeloma

This article is from The Cancer Letter archive.

Vol. 28 No. 7 | July 29, 2005

Download PDF Visit The Full Archive

Related Articles

Brown Needs Decision By March 31; Sander Decline HEW Offer

March 4, 1977

Abraxane and Gemcitabine Improves Overall Survival

November 30, 2012

Parkinson Heads Oncology At Amgen

May 2, 2003

NCI To Pay 34 Percent Of Grants, At 155 Payline; $100 Million for Centers to Fund All Core Grants

January 29, 1988

Is Everyone in Academic Medicine Unhappy? Or is it Just MD Anderson?

December 12, 2014

In Brief: Columbia University Double Lab Space; GM Cancer Awards to Suit, Folkman, Nurse

June 6, 1997